About 4-[3-[3-(4-chlorophenyl)propanoylamino]-1-methyl-2-oxo-3H-1,4-benzodiazepin-5-yl]benzamide
4-[3-[3-(4-chlorophenyl)propanoylamino]-1-methyl-2-oxo-3H-1,4-benzodiazepin-5-yl]benzamide (PubChem CID 10183975) has the molecular formula C26H23ClN4O3
and a molecular weight of 474.95 g/mol. Its IUPAC name is 4-[3-[3-(4-chlorophenyl)propanoylamino]-1-methyl-2-oxo-3H-1,4-benzodiazepin-5-yl]benzamide.
Molecular Properties
| Compound Name | 4-[3-[3-(4-chlorophenyl)propanoylamino]-1-methyl-2-oxo-3H-1,4-benzodiazepin-5-yl]benzamide |
| PubChem CID | 10183975 |
| Molecular Formula | C26H23ClN4O3 |
| Molecular Weight | 474.95 g/mol |
| Exact Mass | 474.15 |
| IUPAC Name | 4-[3-[3-(4-chlorophenyl)propanoylamino]-1-methyl-2-oxo-3H-1,4-benzodiazepin-5-yl]benzamide |
| SMILES | CN1C(=O)C(NC(=O)CCc2ccc(Cl)cc2)N=C(c2ccc(C(N)=O)cc2)c2ccccc21 |
| InChI | InChI=1S/C26H23ClN4O3/c1-31-21-5-3-2-4-20(21)23(17-9-11-18(12-10-17)24(28)33)30-25(26(31)34)29-22(32)15-8-16-6-13-19(27)14-7-16/h2-7,9-14,25H,8,15H2,1H3,(H2,28,33)(H,29,32) |
| InChIKey | YRFUXKDRHRWYCT-UHFFFAOYSA-N |
| XLogP | 3.33 |
| TPSA | 104.86 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
| MW ≤ 500 | 474.95 |
| LogP ≤ 5 | 3.33 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Analyze 4-[3-[3-(4-chlorophenyl)propanoylamino]-1-methyl-2-oxo-3H-1,4-benzodiazepin-5-yl]benzamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 4-[3-[3-(4-chlorophenyl)propanoylamino]-1-methyl-2-oxo-3H-1,4-benzodiazepin-5-yl]benzamide?
The IUPAC name of 4-[3-[3-(4-chlorophenyl)propanoylamino]-1-methyl-2-oxo-3H-1,4-benzodiazepin-5-yl]benzamide (CID 10183975) is 4-[3-[3-(4-chlorophenyl)propanoylamino]-1-methyl-2-oxo-3H-1,4-benzodiazepin-5-yl]benzamide.
What is the SMILES notation for 4-[3-[3-(4-chlorophenyl)propanoylamino]-1-methyl-2-oxo-3H-1,4-benzodiazepin-5-yl]benzamide?
The canonical SMILES for 4-[3-[3-(4-chlorophenyl)propanoylamino]-1-methyl-2-oxo-3H-1,4-benzodiazepin-5-yl]benzamide is CN1C(=O)C(NC(=O)CCc2ccc(Cl)cc2)N=C(c2ccc(C(N)=O)cc2)c2ccccc21.
What is the InChIKey of 4-[3-[3-(4-chlorophenyl)propanoylamino]-1-methyl-2-oxo-3H-1,4-benzodiazepin-5-yl]benzamide?
The InChIKey is YRFUXKDRHRWYCT-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H23ClN4O3/c1-31-21-5-3-2-4-20(21)23(17-9-11-18(12-10-17)24(28)33)30-25(26(31)34)29-22(32)15-8-16-6-13-19(27)14-7-16/h2-7,9-14,25H,8,15H2,1H3,(H2,28,33)(H,29,32).
What are the key properties of 4-[3-[3-(4-chlorophenyl)propanoylamino]-1-methyl-2-oxo-3H-1,4-benzodiazepin-5-yl]benzamide?
4-[3-[3-(4-chlorophenyl)propanoylamino]-1-methyl-2-oxo-3H-1,4-benzodiazepin-5-yl]benzamide has a molecular weight of 474.95 g/mol, XLogP of 3.33, 6 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[3-[3-(4-chlorophenyl)propanoylamino]-1-methyl-2-oxo-3H-1,4-benzodiazepin-5-yl]benzamide is sourced from PubChem (CID 10183975), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).